AB Soft The Brief Pain Inventory ii - Manual (Page 15)

25
28. Liang SY, Yates P, Edwards H, Tsay SL. Factors influencing
opioid-taking self-efficacy and analgesic adherence in
Taiwanese outpatients with cancer. Psychooncology, 3/2008.
29. Lin CC. Comparison of the effects of perceived self-efficacy
on coping with chronic cancer pain and coping with chronic
low back pain. Clin J Pain 14(4): 303-310, 12/1998.
30. Lin CC, Wang P, Lai YL, Lin CL, Tsai SL, Chen TT. Identifying
attitudinal barriers to family management of cancer pain in
palliative care in Taiwan. Palliat Med 14(6): 463-470, 11/2000.
31. Lin CC. Barriers to the analgesic management of cancer
pain: a comparison of attitudes of Taiwanese patients and
their family caregivers. Pain 88(1): 7-14, 10/2000.
32. Lin CC. Congruity of cancer pain perceptions between
Taiwanese patients and family caregivers: relationship to
patients' concerns about reporting pain and using analgesics.
J Pain Symptom Manage 21(1): 18-26, 1/2001.
33. Lin CC, Lai YL, Ward SE. Effect of cancer pain on performance
status, mood states, and level of hope among Taiwanese
cancer patients. J Pain Symptom Manage 25(1): 29-37,
1/2003.
34. Lin JT, Mathew P. Cancer pain management in prisons: a
survey of primary care practitioners and inmates. J Pain
Symptom Manage 29(5): 466-473, 5/2005.
35. Long HJ, III, Monk BJ, Huang HQ, Grendys EC, Jr., McMeekin
DS, Sorosky J, Miller DS, Eaton LA, Fiorica JV. Clinical results
and quality of life analysis for the MVAC combination
(methotrexate, vinblastine, doxorubicin, and cisplatin) in
carcinoma of the uterine cervix: A Gynecologic Oncology
Group study. Gynecol Oncol 100(3): 537-543, 3/2006.
36. Lundorff L, Peuckmann V, Sjogren P. Pain management of
opioid-treated cancer patients in hospital settings in
Denmark. Acta Anaesthesiol Scand 52(1): 137-142, 1/2008.
37. Maltoni M, Scarpi E, Modonesi C, Passardi A, Calpona S,
Turriziani A, Speranza R, Tassinari D, Magnani P, Saccani D,
Montanari L, Roudnas B, Amadori D, Fabbri L, Nanni O, Raulli
26
P, Poggi B, Fochessati F, Giannunzio D, Barbagallo ML,
Minnotti V, Betti M, Giordani S, Piazza E, Scapaticci R, Ferrario
S. A validation study of the WHO analgesic ladder: a two-step
vs three-step strategy. Support Care Cancer 13(11): 888-894,
11/2005.
38. McMillan SC, Tittle M, Hagan S, Laughlin J. Management of
pain and pain-related symptoms in hospitalized veterans with
cancer. Cancer Nurs 23(5): 327-336, 10/2000.
39. McMillan SC, Tofthagen C, Morgan MA. Relationships among
pain, sleep disturbances, and depressive symptoms in
outpatients from a comprehensive cancer center. Oncol Nurs
Forum 35(4): 603-611, 7/2008.
40. McQuellon RP, Thaler HT, Cella D, Moore DH. Quality of life
(QOL) outcomes from a randomized trial of cisplatin versus
cisplatin plus paclitaxel in advanced cervical cancer: a
Gynecologic Oncology Group study. Gynecol Oncol 101(2):
296-304, 5/2006.
41. McQuellon RP, Danhauer SC, Russell GB, Shen P, Fenstermaker
J, Stewart JH, Levine EA. Monitoring health outcomes
following cytoreductive surgery plus intraperitoneal
hyperthermic chemotherapy for peritoneal carcinomatosis.
Ann Surg Oncol 14(3): 1105-1113, 3/2007.
42. Meghani SH, Keane A. Preference for analgesic treatment for
cancer pain among African Americans. J Pain Symptom
Manage 34(2): 136-147, 8/2007.
43. Monk BJ, Huang HQ, Cella D, Long HJ, III. Quality of life
outcomes from a randomized phase III trial of cisplatin with or
without topotecan in advanced carcinoma of the cervix: a
Gynecologic Oncology Group Study. J Clin Oncol 23(21):
4617-4625, 7/2005.
44. Mystakidou K, Parpa E, Tsilika E, Mavromati A, Smyrniotis V,
Georgaki S, Vlahos L. Long-term management of noncancer
pain with transdermal therapeutic system-fentanyl. J Pain 4(6):
298-306, 8/2003.
45. Mystakidou K, Tsilika E, Parpa E, Kouloulias V, Kouvaris I,
Georgaki S, Vlahos L. Long-term cancer pain management in